Gene · 7913
Papers1,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia. | J Pers Med | 2022 | 36294746 | PubTator, text mining | PubMed |
| Subtype-specific 3D genome alteration in acute myeloid leukaemia. | Nature | 2022 | 36289338 | PubTator, text mining | PubMed |
| Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation. | PLoS Genet | 2022 | 36288392 | PubTator, text mining | PubMed |
| Novel molecular mechanisms in Alzheimer's disease: The potential role of DEK in disease pathogenesis. | Front Aging Neurosci | 2022 | 36275000 | PubTator, text mining | PubMed |
| In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia. | Sci Rep | 2022 | 36271116 | PubTator, text mining | PubMed |
| RAD51AP1 regulates ALT-HDR through chromatin-directed homeostasis of TERRA. | Mol Cell | 2022 | 36265488 | PubTator, text mining | PubMed |
| Engineering neoantigen vaccines to improve cancer personalized immunotherapy. | Int J Biol Sci | 2022 | 36263174 | PubTator, text mining | PubMed |
| Gain of Chromosome 6p Correlates with Severe Anaplasia, Cellular Hyperchromasia, and Extraocular Spread of Retinoblastoma. | Ophthalmol Sci | 2022 | 36246172 | PubTator, text mining | PubMed |
| Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2. | PLoS One | 2022 | 36190960 | PubTator, text mining | PubMed |
| Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma. | Front Oncol | 2022 | 36185191 | PubTator, text mining | PubMed |
| The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals. | Clin Proteomics | 2022 | 36171541 | PubTator, text mining | PubMed |
| Predictive value of retinal nerve fibre layer thickness for postoperative visual improvement in patients with pituitary macroadenoma. | BMJ Open Ophthalmol | 2022 | 36161840 | PubTator, text mining | PubMed |
| The role of miR-200 family in the regulation of hallmarks of cancer. | Front Oncol | 2022 | 36158660 | PubTator, text mining | PubMed |
| Lead-exposure associated miRNAs in humans and Alzheimer's disease as potential biomarkers of the disease and disease processes. | Sci Rep | 2022 | 36153426 | PubTator, text mining | PubMed |
| Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1-antibody-drug conjugate. | Blood Adv | 2022 | 36149945 | PubTator, text mining | PubMed |
| Identification of the Regulatory Targets of miR-3687 and miR-4417 in Prostate Cancer Cells Using a Proteomics Approach. | Int J Mol Sci | 2022 | 36142477 | PubTator, text mining | PubMed |
| Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology. | Curr Oncol | 2022 | 36135060 | PubTator, text mining | PubMed |
| Deciphering the endometrial immune landscape of RIF during the window of implantation from cellular senescence by integrated bioinformatics analysis and machine learning. | Front Immunol | 2022 | 36131919 | PubTator, text mining | PubMed |
| Comprehensive analysis of fifteen hub genes to identify a promising diagnostic model, regulated networks, and immune cell infiltration in acute kidney injury. | J Clin Lab Anal | 2022 | 36125921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7913/papers?page=12